Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Dual-peptide research advantage Combining BPC-157 and TB-500 in a single vial allows researchers to simplify preparation and maintain consistency across experimental workflows
Avoid stacking AOD-9604 with other direct lipolytic compounds without professional guidance
Cancer cell radioresistance is the primary cause of the decreased curability of nonsmall cell lung cancer (NSCLC) observed in patients receiving definitive radiotherapy (RT)
AOD 9604 (5mg) AOD-9604 is a synthetic peptide derived from a modified fragment of human growth hormone (hGH), corresponding to the hGH 176191 region and containing a disulfide bridge
Helps to reduce the frequency of migraine headaches including associated nausea and vomiting when taken as a prophylatic/preventative
US$ 26.85
US$ 21.32
US$ 26.48
US$ 25.09
